Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is testing and implementing an equity-focused, community-based intervention that improves women's access to cervical cancer screening and adherence to follow up after an abnormal result. The study's objective is to assess and compare the feasibility of different methods of distributing at-home HPV testing kits for cervical cancer screening among individuals who are under-screened.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 25 lat
- •Nienaruszona szyjka macicy
- •Nie badana na raka szyjki macicy przez ostatnie 3 lata (dla osób 25-64 lat) lub 5 lat (dla osób 65+)
- •Posiadanie telefonu komórkowego odbierającego wiadomości SMS i konta e-mail
- •Dostęp do internetu i możliwość korzystania z aplikacji mobilnej
- •Umiejętność czytania, pisania i rozumienia angielskiego
✗ Disqualifies
- •Nieprawidłowe krwawienia lub wydzielina z pochwy
- •Historia nowotworów narządów rozrodczych
- •Osłabiony system odpornościowy
- •Obecna ciąża lub okres 6 tygodni po porodzie
- •Leczenie przedrakowych zmian szyjki macicy w ostatnich 25 latach
Simplified criteria — AI translation
Trial details
- Minimum age
- 25 Years
- Last updated (source)
- July 27, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Washington University School of Medicine
St Louis, United States
Trial contact
Michelle Silver, PhD, ScM
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.